EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Inno-Gene's enterprise value is zł11.13 Mil.
Inno-Gene's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was zł0.42 Mil. Therefore, Inno-Gene's EV-to-Revenue for today is 26.82.
The historical rank and industry rank for Inno-Gene's EV-to-Revenue or its related term are showing as below:
WAR:IGN'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.44 Med: 5.38 Max: 152.33
Current: 26.82
During the past 13 years, the highest EV-to-Revenue of Inno-Gene was 152.33. The lowest was 0.44. And the median was 5.38.
WAR:IGN's EV-to-Revenue is ranked worse than 90.05% of 221
companies
in the Medical Diagnostics & Research industry
Industry Median: 3.03
vs WAR:IGN: 26.82
As of today (2024-06-22), Inno-Gene's stock price is zł1.78.
Inno-Gene's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was zł0.07. Therefore, Inno-Gene's PS Ratio for today is 25.07.
Inno-Gene EV-to-Revenue Historical Data
The historical data trend for Inno-Gene's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Inno-Gene's EV-to-Revenue
For the Diagnostics & Research subindustry, Inno-Gene's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inno-Gene's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Inno-Gene's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Inno-Gene's EV-to-Revenue falls into.
Inno-Gene's current Enterprise Value is zł11.13 Mil.
Inno-Gene's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.42 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inno-Gene's share price for today is zł1.78.
Inno-Gene's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.07.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inno-Gene EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Inno-Gene's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Inno-Gene SA operates a DNA research facility that deals with genetic diagnostics, research and development. The company provides services in the field of genetic medical diagnosis, including diagnosis of microbial infections and innate predispositions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WAR:IGN has been successfully added to your 